Monday, August 4, 2014

AbbVie Brain Tumor Treatment Gets Orphan Designation

AbbVie said Monday that European and U.S. regulators have granted orphan drug designation to a potential brain tumor treatment.



from WSJ.com: US Business http://ift.tt/1ueYFDe

via IFTTT

No comments:

Post a Comment